| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 04/13/2005 | CN1606549A Thiazolidine derivative and medicinal use thereof |
| 04/13/2005 | CN1196700C Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 04/13/2005 | CN1196689C Continuous process for prepn. of pesticidal chorothiazoles |
| 04/13/2005 | CN1196688C Intermediate for synthetizing thiazolium derivative and its prepn. method |
| 04/13/2005 | CN1196686C Method for storing quaternary ammonium salt |
| 04/12/2005 | US6878828 Coupling cysteine with benzonitrile, then esterifying, alkylating, hydrolyzing and reacting with acids to form 2-methylcysteine |
| 04/12/2005 | US6878827 Process for producing anhydride of aminothiazole derivative |
| 04/12/2005 | US6878743 Controlling apoptosis; central nervous system disorders |
| 04/12/2005 | US6878742 Alzheimer's disease; Down's syndrome |
| 04/12/2005 | CA2252576C Use of dipeptidyl peptidase iv inhibitors for lowering the blood glucose level in mammals |
| 04/12/2005 | CA2122571C Adhesion receptor antagonists |
| 04/07/2005 | WO2005030794A2 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | WO2005030740A1 Thiazoline derivative and use of the same |
| 04/07/2005 | WO2005030737A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 04/07/2005 | WO2005030736A1 Derivatives of 1,3-diones having a herbicidal activity |
| 04/07/2005 | WO2005030705A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030704A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2004112709A3 Inhibitors of cathepsin s |
| 04/07/2005 | WO2004014871A8 Vanilloid receptor ligands and their use in treatments |
| 04/07/2005 | US20050075503 Substituted thiazoles |
| 04/07/2005 | US20050075390 HIV protease inhibitors |
| 04/07/2005 | US20050075379 5-(ester-substituted benzyl or benzylidene)-thiazolidine-2,4-diones; readily metabolized by the physiological metabolic drug detoxification systems without loss of therapeutic benefit; lower side effects and toxicity in patients with elevated or compromised liver function |
| 04/07/2005 | US20050075378 Modulators of peroxisome proliferator activated receptors (ppar) |
| 04/07/2005 | US20050075367 Ester compound and medicinal use thereof |
| 04/07/2005 | US20050075345 1,2,4-Oxadiazoline-5-one or thiazolidine-2,4-dione derivatives; hypertensive, antiinflammatory, antiallergen, antiischemic, antihistamine, bronchodilator, and anticarcinogenic agents; cardiovascular, skin, gastrointestinal, and respiratory system disorders; cyclization, catalytic hydrogenation |
| 04/07/2005 | US20050075338 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 04/07/2005 | US20050075323 Beta3 adrenergic receptor agonists and uses thereof |
| 04/07/2005 | US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials |
| 04/07/2005 | CA2540355A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 04/07/2005 | CA2539823A1 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | CA2539744A1 Derivatives of 1,3-diones having a herbicidal activity |
| 04/07/2005 | CA2539117A1 Inhibitors of histone deacetylase |
| 04/06/2005 | EP1520025A2 Nucleic acid molecules involved in the synthesis of melithiazols |
| 04/06/2005 | EP1519932A1 Bisarylsulfonamide compounds and their use in cancer therapy |
| 04/06/2005 | EP1519928A1 Method for producing heterocyclic fluoroalkenyl sulfones |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1519723A1 Novel glucagon antagonists/inverse agonists |
| 04/06/2005 | EP1465882A4 Hetrocyclic modulators of nuclear receptors |
| 04/06/2005 | EP1406898B1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 04/06/2005 | CN1604897A 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 04/06/2005 | CN1603316A High refractive index, uv-curable monomers and coating compositions prepared therefrom |
| 04/06/2005 | CN1603307A Cyanoacrylate derivatives and their preparation method and biological activity |
| 04/06/2005 | CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 04/06/2005 | CN1195761C Cephalosporin Intermediates |
| 04/06/2005 | CN1195753C Fused-benzene derivatives useful as herbicides |
| 04/06/2005 | CN1195747C 8, 8a-dihydro-indeno [1, 2-d] thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents |
| 04/06/2005 | CN1195739C 2-sulfamoylbenzoic acid derivatives |
| 04/06/2005 | CN1195734C Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same |
| 04/05/2005 | US6875884 Urea derivatives as inhibitors for CCR-3 receptor |
| 04/05/2005 | US6875883 Forming a phenyl-thiazoles chemical intermediates for making antioxidants, ferrielectric liquid crystal dopant, picornaviral viricides, antiinflammatory agents, anti-asthma agents, and fibringoen antagonists |
| 04/05/2005 | US6875882 Ferroelectric liquid crystals, antihistamines, antiinflammatory agents, viricides |
| 04/05/2005 | US6875873 Oxidative dyeing of keratin fibers |
| 04/05/2005 | US6875768 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method for using the same |
| 04/05/2005 | US6875765 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family |
| 04/05/2005 | US6875764 Urea and thiourea compounds useful for treatment of coccidiosis |
| 04/05/2005 | US6875760 Glucagon antagonists/inverse agonists |
| 04/05/2005 | US6875759 Anticancer agents; analgesics |
| 03/31/2005 | WO2005028456A1 Thiazole derivatives as cannabinoid receptor modulators |
| 03/31/2005 | WO2005028453A1 Phenylacetic acid derivative, process for producing the same, and use |
| 03/31/2005 | WO2005028429A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 03/31/2005 | WO2004108133A3 Modulators of vr1 receptor |
| 03/31/2005 | WO2004098591A3 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
| 03/31/2005 | WO2004073606A3 Sulfonamide derivatives as ppar modulators |
| 03/31/2005 | US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents |
| 03/31/2005 | US20050070581 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease |
| 03/31/2005 | US20050070538 Compounds and uses thereof in modulating amyloid beta |
| 03/31/2005 | US20050070533 Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use |
| 03/31/2005 | US20050070532 Peroxisome proliferator activated receptors (PPARS); for inhibiting formation of adipocytes; for treatment of obesity, diabetes, hyperinsulinemia, and polycystic ovary syndrome |
| 03/31/2005 | US20050070517 Oxazol/thiazol-derivatives activators of the hppar-alpha receptor |
| 03/31/2005 | US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response |
| 03/31/2005 | US20050069522 Combination pharmaceutical agents as inhibitors of HCV replication |
| 03/31/2005 | CA2539554A1 Phenylacetic acid derivative, process for producing the same, and use |
| 03/31/2005 | CA2538454A1 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
| 03/31/2005 | CA2521811A1 Haloalkyl containing compounds as cysteine protease inhibitors |
| 03/30/2005 | EP1519192A2 HIV Protease inhibitor conjugates and antibodies useful in ummunoassay |
| 03/30/2005 | EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia |
| 03/30/2005 | EP1517907A2 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 03/30/2005 | EP1517882A1 Amide linker peroxisome proliferator activated receptor modulators |
| 03/30/2005 | EP1517680A1 Benzoic acid derivatives as modulators of ppar alpha and gamma |
| 03/30/2005 | EP1444197B1 Novel phenyl-propargylether derivatives |
| 03/30/2005 | EP0877740B1 Thiol derivatives with metallopeptidase inhibitory activity |
| 03/30/2005 | CN1602310A Benzothiazoles compound |
| 03/30/2005 | CN1602196A Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/30/2005 | CN1194964C P-methylsulfonyl phenylacrylate derivative and its prepn process and anti-inflammatory effect |
| 03/29/2005 | US6872852 Polyamine analogues as cytotoxic agents |
| 03/29/2005 | US6872740 4-(heteroarylethyl)-4,5-dihydro-1,3-thiazol-2-ylamine or salt, useful for treating an illness, which involves an abnormal production of nitric oxide (NO) by induction of an inducible NO-synthase |
| 03/29/2005 | US6872737 Drugs such as 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5 -dione inhibitors of glycogen synthase kinase-3 (GSK-3), for prophylaxis of neurodegenerative disorders, cancer, hyperplasia, psoriasis, arteriosclerosis or restinosis |
| 03/29/2005 | US6872735 LFA-1 antagonist compounds |
| 03/24/2005 | WO2005026137A2 Modulators of atp-binding cassette transporters |
| 03/24/2005 | WO2005026136A2 2, 2'-azino-bis-thiazolines and uses thereof as air- and water- stable radical precursors |
| 03/24/2005 | WO2005026134A1 Organic compounds |
| 03/24/2005 | WO2005026131A1 Transition state structure and inhibitors of thymidine phosphorylases |
| 03/24/2005 | WO2005026127A1 Plasminogen activator inhibitor-1 inhibitor |
| 03/24/2005 | WO2005026114A1 Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses |
| 03/24/2005 | WO2005025555A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 03/24/2005 | WO2005025356A2 Orthopedic insoles for protecting skin from stretching and cracking in the area of the five metatarsal heads of the forefoot |
| 03/24/2005 | WO2004098494A3 Compounds, compositions, and methods |
| 03/24/2005 | WO2004089922A3 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 03/24/2005 | WO2004072101A3 Phenylglycine derivatives useful as serine protease inhibitors |